NGM Bio Reports Recent Highlights and First Quarter 2019 Financial Results

NEXT STORY
Vascepa® to Be Featured in Multiple Scientific Sessions at the National Lipid Association Annual Meeting
PREV STORY
National Lipid Association Statement Paper Provides Clinicians with Updated Guidance for Enhanced Value of PCSK9 Use in Select Patient Populations
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BrainsWay Announces Successful Results in Pivotal Multicenter Study Evaluating Deep Transcranial Magnetic Stimulation System as an Aid in Smoking Cessation

author_avatar
NASDAQ Market News

Curetis Reports Results of the Annual Shareholder Meeting Held on June 23, 2017

Curetis Reports Results of the Annual Shareholder Meeting Held on June 23, 2017 - ...

author_avatar
NASDAQ Market News

Allergy Therapeutics secures virus-like particle (“VLP”) technology platform to broaden vaccine pipeline through licensing agreements with Saiba AG and DeepVax GmbH

author_avatar
NASDAQ Market News